Chromatographic evaluation and QSAR optimization for benzoic acid analogues against carbonic anhydrase III

J Enzyme Inhib Med Chem. 2015 Jun;30(3):420-9. doi: 10.3109/14756366.2014.940939. Epub 2014 Jul 28.

Abstract

An HPLC-size exclusion method was developed as an assay method to evaluate the binding of tested compounds with carbonic anhydrase III (CAIII) enzyme. Inhibition of CAIII by a group of benzoic acid analogues was characterized by vacancy (negative) peak intensity representing the fraction of the compounds bound with CAIII enzyme. Interestingly, p-hydroxyl benzoic acid and aspirin were found potent inhibitors against CAIII with affinity constants of 9954 and 9013 M(-1) respectively. Affinity values of twenty training compounds were modeled against thirty-five descriptors derived from their structures. Strong correlation was obtained between the affinity values and the formal charge of the molecules. Docking studies on training set compounds generated consensus scores having a strong agreement with affinity factors obtained from the chromatographic analysis.

Keywords: Benzoic acid analogues; carbonic anhydrase III; vacancy chromatography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzoates / chemical synthesis
  • Benzoates / chemistry
  • Benzoates / pharmacology*
  • Carbonic Anhydrase III / antagonists & inhibitors*
  • Carbonic Anhydrase III / metabolism
  • Carbonic Anhydrase Inhibitors / chemical synthesis
  • Carbonic Anhydrase Inhibitors / chemistry
  • Carbonic Anhydrase Inhibitors / pharmacology*
  • Chromatography, High Pressure Liquid
  • Dose-Response Relationship, Drug
  • Humans
  • Molecular Docking Simulation
  • Molecular Structure
  • Quantitative Structure-Activity Relationship*

Substances

  • Benzoates
  • Carbonic Anhydrase Inhibitors
  • Carbonic Anhydrase III